Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIO | BRBR | LNTH | ||
| Company | Bio-Rad Laboratories | Bellring Brands Inc Cl A | Lantheus Holdings | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 323.03 | 75.07 | 86.82 | ||
| High | 326.45 | 76.68 | 88.52 | ||
| Low | 320.32 | 74.89 | 85.24 | ||
| Last | 325.58 | 76.49 | 87.32 | ||
| Change | +1.89 | +2.08 | +0.87 | ||
| % Change | +0.58% | +2.80% | +1.01% | ||
| Volume | 159,500 | 1,196,200 | 1,483,900 | ||
| 20-Day Average Volume | 217,840 | 1,020,080 | 1,546,235 | ||
| Previous Close | 323.69 | 74.41 | 86.45 | ||
| Industry | Medical Products | Medical Products | Medical Products | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 347.16 | 69.74 | 94.56 | ||
| 20-Day Raw Stochastic | 23.49% | 98.50% | 28.51% | ||
| 20-Day Relative Strength | 43.58% | 83.47% | 40.79% | ||
| Weighted Alpha | +3.95 | +62.43 | -7.44 | ||
| Today's Opinion | 40% Buy | 100% Buy | 24% Sell | ||
| Previous Opinion | 40% Buy | 100% Buy | 8% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.04% since 11/14/24 | +5.55% since 11/14/24 | +8.02% since 11/14/24 | ||
| Low | 306.42 on 11/18/24 | 67.00 on 11/19/24 | 75.00 on 11/19/24 | ||
| High | 349.07 on 11/15/24 | 76.68 on 11/21/24 | 88.52 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | -5.11% since 10/21/24 | +15.88% since 10/21/24 | -22.09% since 10/21/24 | ||
| Low | 306.42 on 11/18/24 | 63.99 on 10/25/24 | 75.00 on 11/19/24 | ||
| High | 387.99 on 11/06/24 | 76.68 on 11/21/24 | 118.21 on 11/04/24 | ||
| 3-Month | |||||
| %Chg | +2.96% since 08/21/24 | +36.27% since 08/21/24 | -13.73% since 08/21/24 | ||
| Low | 306.42 on 11/18/24 | 54.56 on 08/23/24 | 75.00 on 11/19/24 | ||
| High | 387.99 on 11/06/24 | 76.68 on 11/21/24 | 118.21 on 11/04/24 | ||
| 6-Month | |||||
| %Chg | +12.48% since 05/21/24 | +31.25% since 05/21/24 | +8.20% since 05/21/24 | ||
| Low | 262.12 on 07/02/24 | 48.06 on 08/05/24 | 75.00 on 11/19/24 | ||
| High | 387.99 on 11/06/24 | 76.68 on 11/21/24 | 126.89 on 07/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,062,346 | 9,616,898 | 6,010,609 | ||
| Shares Outstanding, K | 27,997 | 129,242 | 69,527 | ||
| Annual Sales | 2,671,260,000 | 1,666,800,000 | 1,296,430,000 | ||
| Annual Net Income | -637,320,000 | 165,500,000 | 326,660,000 | ||
| Last Quarter Sales | 649,730,000 | 515,400,000 | 378,730,000 | ||
| Last Quarter Net Income | 653,170,000 | 73,700,000 | 131,090,000 | ||
| 60-Month Beta | 0.93 | 0.84 | 0.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.01 on 10/30/24 | 0.51 on 11/18/24 | 1.70 on 11/06/24 | ||
| Latest Earnings Date | 10/30/24 | 11/18/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 30.51 | 37.96 | 12.83 | ||